Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases.
about
IMMUNOLOGY OF TUBERCULOSISNovel adjunctive therapies for the treatment of tuberculosisMatrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasisAssessment of treatment response in tuberculosisMycobacterium tuberculosis dysregulates MMP/TIMP balance to drive rapid cavitation and unrestrained bacterial proliferationMatrix Metalloproteinases in Tuberculosis-Immune Reconstitution Inflammatory Syndrome and Impaired Lung Function Among Advanced HIV/TB Co-infected Patients Initiating Antiretroviral TherapyHypoxia and tissue destruction in pulmonary TBGender-dependent differences in plasma matrix metalloproteinase-8 elevated in pulmonary tuberculosis.Membrane Type 1 Matrix Metalloproteinase Regulates Monocyte Migration and Collagen Destruction in Tuberculosis.Permutations of time and place in tuberculosisHemostatic Changes Associated With Increased Mortality Rates in Hospitalized Patients With HIV-Associated Tuberculosis: A Prospective Cohort StudyAntimycobacterial drugs modulate immunopathogenic matrix metalloproteinases in a cellular model of pulmonary tuberculosis.Advancing host-directed therapy for tuberculosis.Tuberculosis, pulmonary cavitation, and matrix metalloproteinases.Induced sputum MMP-1, -3 & -8 concentrations during treatment of tuberculosis.Immune reconstitution inflammatory syndrome in HIV-infected patientsNeutrophil-Derived MMP-8 Drives AMPK-Dependent Matrix Destruction in Human Pulmonary TuberculosisTargeting Batf2 for infectious diseases and cancer.Cathepsin K Contributes to Cavitation and Collagen Turnover in Pulmonary TuberculosisHost-directed therapy targeting the Mycobacterium tuberculosis granuloma: a reviewTuberculosis: time for a new perspective?HIV-1 and the immune response to TB.Procollagen III N-terminal propeptide and desmosine are released by matrix destruction in pulmonary tuberculosisThe effect of HIV-related immunosuppression on the risk of tuberculosis transmission to household contacts.Matrix metalloproteinases and tissue damage in HIV-tuberculosis immune reconstitution inflammatory syndrome.Update in tuberculosis and nontuberculous mycobacterial disease 2012.Mycobacterium tuberculosis infection of the 'non-classical immune cell'.Doxycycline as an anti-inflammatory agent: updates in dermatology.Early Secretory Antigenic Target-6 Drives Matrix Metalloproteinase-10 Gene Expression and Secretion in TuberculosisMatrix Degradation in Human Immunodeficiency Virus Type 1-Associated Tuberculosis and Tuberculosis Immune Reconstitution Inflammatory Syndrome: A Prospective Observational Study.Cerebrospinal fluid matrix metalloproteinase 9 levels, blood-brain barrier permeability, and treatment outcome in tuberculous meningitis.Recognizing drug targets using evolutionary information: implications for repurposing FDA-approved drugs against Mycobacterium tuberculosis H37Rv.Host-Directed Therapeutic Strategies for Tuberculosis.Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease.Inhibition of Tissue Matrix Metalloproteinases Interferes with Mycobacterium tuberculosis-Induced Granuloma Formation and Reduces Bacterial Load in a Human Lung Tissue Model.Elemental Ingredients in the Macrophage Cocktail: Role of ZIP8 in Host Response to Mycobacterium tuberculosis.Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection.Matrix metalloproteinase inhibitors enhance the efficacy of frontline drugs against Mycobacterium tuberculosis.Diverse cavity types and evidence that mechanical action on the necrotic granuloma drives tuberculous cavitation.Tuberculosis and lung damage: from epidemiology to pathophysiology.
P2860
Q22241115-0C8BB357-E046-495A-9189-E94CD55B5F5FQ26829957-EB340A73-670A-4750-82D4-EE5AB5BF65DAQ28256930-0616A46A-3C0F-4D32-B0A9-4A71E5ABCDBDQ28384421-02942D31-D2B8-49FC-9808-1FC814E64ACDQ28385840-5F8280C7-8D1A-4E9B-8513-9B92469F55D4Q28389802-9382455D-F158-44B3-A830-2DF92E69F17AQ28817961-DE13EB39-2732-4030-8CEC-DD79EF834DCEQ30371254-A2377B11-A2D1-42CC-9743-76304E45FDB1Q30375886-8DBC60E6-65CE-4357-8AC1-D879B6875655Q30378562-D7C9905B-D2CC-42DF-AE03-6AA121660AE3Q33712746-19B3B674-6432-4E2D-A260-6B9F61447F9AQ34058316-A0FFEE67-A86A-42D9-93EC-2AEF27EBD054Q34466861-93149761-7FCB-43EB-9420-142E45342E41Q34480272-2428EDA8-1499-497D-ADE4-14124CC0E9F7Q34684277-99273097-BE56-49BA-8420-AF2011458C2CQ35100818-6B26108E-AB4A-420D-83BC-201013A7FADAQ35634195-73FA0F42-C8C2-4FC0-9466-A13ECF2DCB13Q36413539-FB6C74BA-3245-465F-BDA9-A6CD67C2B9C3Q36487876-360A76A5-49A9-45F9-AEBD-4326A0BA8982Q36653997-F33022F8-38FA-4553-9883-AD0E5FE2AB52Q36784190-B82097AE-99AA-4E92-ABE7-D248256FEF8AQ36815449-1B8AA77E-05FC-4FC1-8B55-ECEF587F1D20Q37247445-E512FCA8-2B89-4BF2-8CD7-0D5056ABA7A9Q37604538-325B2033-17B1-45D7-8E6E-0453C9A15EA7Q37712261-E15CE353-CF95-4F12-BCAD-CDE2B4EE7AC8Q38152788-02A45AF0-5308-4C2F-B0DC-479851F13502Q38388252-43A88EFF-CE95-484E-A85E-5BE180E75AF1Q38779399-41EB3D03-3748-4F0E-AA22-ADCE9BD71A6AQ38921337-A5D35FE5-79C6-4C97-A5A6-22167DE65C97Q39569711-D49A47E5-4DF8-483A-9CA4-1622F27BD641Q40124133-639341FF-E85F-4FDE-8E37-89739F80AA19Q40475389-D8E294C3-CF4B-458D-9F2D-AAC61B477DE6Q45006012-89F2BEFD-A278-4B07-B766-152ECA78B905Q46262252-370E8900-9B71-4C0C-9E0F-F679E66E9735Q47102368-F332DDF6-FC4B-4AFE-B55E-23AAF123A7CBQ47108126-1C506CF8-EAD1-4494-9377-5FC25DD097C8Q50131423-96A3EBF8-03B2-4CD2-9832-F9645F9E0C35Q52561219-B9649F69-E2DE-4A0C-91FB-7CD4085F0623Q54213684-3764CFA5-F35C-4DFC-B0FA-CF51A620E7D2Q54264691-C2961ACB-037B-4693-9FC5-CBFBE15A69FC
P2860
Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases.
@ast
Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases.
@en
Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases.
@nl
type
label
Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases.
@ast
Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases.
@en
Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases.
@nl
prefLabel
Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases.
@ast
Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases.
@en
Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases.
@nl
P2093
P2860
P50
P1476
Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases.
@en
P2093
Ann Williams
Bernadette Pedersen
Dominic L Kelly
Francesco A Mauri
Jeanine M D'Armiento
Jon S Friedland
Julia A Tree
Liku Tezera
Luísa Saraiva
Shivani Singh
P2860
P304
P356
10.1164/RCCM.201110-1769OC
P407
P577
2012-02-16T00:00:00Z